Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.06666954 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.06666954 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.77275444 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.77275444 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.35491646 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.16630550 |
7 | tryptophan catabolic process (GO:0006569) | 5.73539662 |
8 | indole-containing compound catabolic process (GO:0042436) | 5.73539662 |
9 | indolalkylamine catabolic process (GO:0046218) | 5.73539662 |
10 | bile acid biosynthetic process (GO:0006699) | 5.72090604 |
11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.69754572 |
12 | kynurenine metabolic process (GO:0070189) | 5.58790300 |
13 | glyoxylate metabolic process (GO:0046487) | 5.53844736 |
14 | tryptophan metabolic process (GO:0006568) | 5.41150878 |
15 | urea metabolic process (GO:0019627) | 5.40744678 |
16 | urea cycle (GO:0000050) | 5.40744678 |
17 | complement activation, alternative pathway (GO:0006957) | 5.38201472 |
18 | sulfur amino acid catabolic process (GO:0000098) | 5.31469894 |
19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25067004 |
20 | cysteine metabolic process (GO:0006534) | 5.21722944 |
21 | negative regulation of fibrinolysis (GO:0051918) | 5.19518745 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10958353 |
23 | protein carboxylation (GO:0018214) | 5.10958353 |
24 | regulation of protein activation cascade (GO:2000257) | 5.09480433 |
25 | daunorubicin metabolic process (GO:0044597) | 5.07079308 |
26 | polyketide metabolic process (GO:0030638) | 5.07079308 |
27 | doxorubicin metabolic process (GO:0044598) | 5.07079308 |
28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01394845 |
29 | regulation of fibrinolysis (GO:0051917) | 5.00919272 |
30 | nitrogen cycle metabolic process (GO:0071941) | 4.97747723 |
31 | regulation of triglyceride catabolic process (GO:0010896) | 4.95103598 |
32 | bile acid metabolic process (GO:0008206) | 4.85486914 |
33 | regulation of complement activation (GO:0030449) | 4.79363305 |
34 | serine family amino acid catabolic process (GO:0009071) | 4.72774104 |
35 | reverse cholesterol transport (GO:0043691) | 4.64534166 |
36 | regulation of cholesterol esterification (GO:0010872) | 4.62481458 |
37 | protein-lipid complex remodeling (GO:0034368) | 4.62064944 |
38 | macromolecular complex remodeling (GO:0034367) | 4.62064944 |
39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.62064944 |
40 | aromatic amino acid family metabolic process (GO:0009072) | 4.60889127 |
41 | homocysteine metabolic process (GO:0050667) | 4.58835123 |
42 | acylglycerol homeostasis (GO:0055090) | 4.57537052 |
43 | triglyceride homeostasis (GO:0070328) | 4.57537052 |
44 | amino-acid betaine metabolic process (GO:0006577) | 4.53929447 |
45 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.52937065 |
46 | tyrosine metabolic process (GO:0006570) | 4.52364840 |
47 | plasma lipoprotein particle clearance (GO:0034381) | 4.43827127 |
48 | primary alcohol catabolic process (GO:0034310) | 4.42881823 |
49 | lysine metabolic process (GO:0006553) | 4.40100110 |
50 | lysine catabolic process (GO:0006554) | 4.40100110 |
51 | cellular glucuronidation (GO:0052695) | 4.39229062 |
52 | phospholipid efflux (GO:0033700) | 4.39017261 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.36027502 |
54 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.29549107 |
55 | negative regulation of sterol transport (GO:0032372) | 4.26705878 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.26705878 |
57 | ethanol oxidation (GO:0006069) | 4.18603341 |
58 | cellular ketone body metabolic process (GO:0046950) | 4.17157061 |
59 | L-serine metabolic process (GO:0006563) | 4.15973047 |
60 | coenzyme catabolic process (GO:0009109) | 4.13437409 |
61 | bile acid and bile salt transport (GO:0015721) | 4.11362251 |
62 | benzene-containing compound metabolic process (GO:0042537) | 4.08995477 |
63 | cholesterol efflux (GO:0033344) | 4.05623884 |
64 | cellular amino acid catabolic process (GO:0009063) | 4.05590349 |
65 | indolalkylamine metabolic process (GO:0006586) | 4.04973641 |
66 | exogenous drug catabolic process (GO:0042738) | 3.99504914 |
67 | imidazole-containing compound metabolic process (GO:0052803) | 3.98646759 |
68 | cellular biogenic amine catabolic process (GO:0042402) | 3.98110640 |
69 | amine catabolic process (GO:0009310) | 3.98110640 |
70 | uronic acid metabolic process (GO:0006063) | 3.96093605 |
71 | glucuronate metabolic process (GO:0019585) | 3.96093605 |
72 | glycine metabolic process (GO:0006544) | 3.96073761 |
73 | positive regulation of lipid catabolic process (GO:0050996) | 3.93614536 |
74 | serine family amino acid metabolic process (GO:0009069) | 3.90097757 |
75 | glutamate metabolic process (GO:0006536) | 3.89267455 |
76 | aldehyde catabolic process (GO:0046185) | 3.88803198 |
77 | plasma lipoprotein particle assembly (GO:0034377) | 3.87003585 |
78 | negative regulation of lipase activity (GO:0060192) | 3.84106889 |
79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.82328401 |
80 | fibrinolysis (GO:0042730) | 3.79699870 |
81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76353624 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 3.76138029 |
83 | acetyl-CoA metabolic process (GO:0006084) | 3.75659786 |
84 | arginine metabolic process (GO:0006525) | 3.73536118 |
85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73193694 |
86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73193694 |
87 | short-chain fatty acid metabolic process (GO:0046459) | 3.72349811 |
88 | response to nitrosative stress (GO:0051409) | 3.70535982 |
89 | phospholipid homeostasis (GO:0055091) | 3.70136775 |
90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69025514 |
91 | organic acid catabolic process (GO:0016054) | 3.68857509 |
92 | carboxylic acid catabolic process (GO:0046395) | 3.68857509 |
93 | drug catabolic process (GO:0042737) | 3.67788236 |
94 | fatty acid beta-oxidation (GO:0006635) | 3.66631831 |
95 | serine family amino acid biosynthetic process (GO:0009070) | 3.66562554 |
96 | cholesterol homeostasis (GO:0042632) | 3.66510482 |
97 | chaperone-mediated protein transport (GO:0072321) | 3.66170977 |
98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65595749 |
99 | fatty acid oxidation (GO:0019395) | 3.65158958 |
100 | complement activation (GO:0006956) | 3.64872095 |
101 | cofactor catabolic process (GO:0051187) | 3.62167695 |
102 | sterol homeostasis (GO:0055092) | 3.60746088 |
103 | ketone body metabolic process (GO:1902224) | 3.60227956 |
104 | complement activation, classical pathway (GO:0006958) | 3.60219450 |
105 | lipid oxidation (GO:0034440) | 3.58946054 |
106 | monocarboxylic acid catabolic process (GO:0072329) | 3.58342646 |
107 | plasma lipoprotein particle organization (GO:0071827) | 3.57587574 |
108 | cytolysis (GO:0019835) | 3.57520492 |
109 | proteasome assembly (GO:0043248) | 3.57173345 |
110 | protein activation cascade (GO:0072376) | 3.56643321 |
111 | ethanol metabolic process (GO:0006067) | 3.38391604 |
112 | ATP synthesis coupled proton transport (GO:0015986) | 3.38307557 |
113 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.38307557 |
114 | establishment of integrated proviral latency (GO:0075713) | 3.33021812 |
115 | biotin metabolic process (GO:0006768) | 3.22997177 |
116 | primary alcohol metabolic process (GO:0034308) | 3.20402779 |
117 | omega-hydroxylase P450 pathway (GO:0097267) | 3.14616579 |
118 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.07566990 |
119 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.05026489 |
120 | epoxygenase P450 pathway (GO:0019373) | 3.04762211 |
121 | purine nucleobase biosynthetic process (GO:0009113) | 3.04084901 |
122 | triglyceride catabolic process (GO:0019433) | 3.03247290 |
123 | chromatin remodeling at centromere (GO:0031055) | 2.97283907 |
124 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94117139 |
125 | CENP-A containing nucleosome assembly (GO:0034080) | 2.91248714 |
126 | respiratory electron transport chain (GO:0022904) | 2.89078946 |
127 | drug metabolic process (GO:0017144) | 2.85949392 |
128 | electron transport chain (GO:0022900) | 2.81333764 |
129 | regulation of plasminogen activation (GO:0010755) | 2.80421551 |
130 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.80175571 |
131 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78617033 |
132 | phenylpropanoid metabolic process (GO:0009698) | 2.78124283 |
133 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.78039022 |
134 | acylglycerol catabolic process (GO:0046464) | 2.75685644 |
135 | neutral lipid catabolic process (GO:0046461) | 2.75685644 |
136 | negative regulation of ligase activity (GO:0051352) | 2.75433298 |
137 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.75433298 |
138 | cellular aldehyde metabolic process (GO:0006081) | 2.75133681 |
139 | intestinal cholesterol absorption (GO:0030299) | 2.72748103 |
140 | ribosomal large subunit biogenesis (GO:0042273) | 2.71247263 |
141 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71162945 |
142 | L-methionine salvage (GO:0071267) | 2.70805351 |
143 | L-methionine biosynthetic process (GO:0071265) | 2.70805351 |
144 | amino acid salvage (GO:0043102) | 2.70805351 |
145 | tetrahydrofolate metabolic process (GO:0046653) | 2.70051321 |
146 | nucleobase biosynthetic process (GO:0046112) | 2.69364970 |
147 | regulation of mitochondrial translation (GO:0070129) | 2.64237105 |
148 | termination of RNA polymerase III transcription (GO:0006386) | 2.62446319 |
149 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.62446319 |
150 | retinal metabolic process (GO:0042574) | 2.61650400 |
151 | L-ascorbic acid metabolic process (GO:0019852) | 2.61389382 |
152 | quinone metabolic process (GO:1901661) | 2.61133660 |
153 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60462242 |
154 | rRNA modification (GO:0000154) | 2.58922438 |
155 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.53357469 |
156 | oxaloacetate metabolic process (GO:0006107) | 2.53114445 |
157 | heme transport (GO:0015886) | 2.50024897 |
158 | glycoside metabolic process (GO:0016137) | 2.49505940 |
159 | acyl-CoA metabolic process (GO:0006637) | 2.49499491 |
160 | thioester metabolic process (GO:0035383) | 2.49499491 |
161 | anterior/posterior axis specification, embryo (GO:0008595) | 2.49497119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.99776578 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88990196 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.63303760 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28807315 |
5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.84846883 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08235457 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86924809 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.38565268 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13915999 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.91323715 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.72511280 |
12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71890296 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.37516813 |
14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.32087553 |
15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.92571652 |
16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.90568961 |
17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.76607186 |
18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.50608410 |
19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.47967328 |
20 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46670728 |
21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.43222973 |
22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.36696444 |
23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34176564 |
24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29026222 |
25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.28543401 |
26 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.26550458 |
27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23136644 |
28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19059824 |
29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14127979 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04019544 |
31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01840138 |
32 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2969425 |
33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99716675 |
34 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96676025 |
35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.96404811 |
36 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76730580 |
37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.71955785 |
38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.71417897 |
39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64047080 |
40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60141771 |
41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.58218331 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56366914 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56061606 |
44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54746928 |
45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53488760 |
46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50078588 |
47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.49131961 |
48 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.48524120 |
49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44354840 |
50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44131223 |
51 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42573208 |
52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.39948826 |
53 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.38871804 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35025189 |
55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34634402 |
56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34329265 |
57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34017626 |
58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32451145 |
59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31267363 |
60 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.28074114 |
61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27937641 |
62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.26798603 |
63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26723952 |
64 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25030092 |
65 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24900248 |
66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.23803689 |
67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.23739797 |
68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23013887 |
69 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22360431 |
70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22209107 |
71 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.21667173 |
72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20706465 |
73 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19725423 |
74 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19725423 |
75 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19725423 |
76 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.19563696 |
77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.15450113 |
78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14091957 |
79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14059720 |
80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14000675 |
81 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12676346 |
82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11901467 |
83 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.11746045 |
84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11173800 |
85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10783109 |
86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09293121 |
87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08929681 |
88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08270143 |
89 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.06981524 |
90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06769209 |
91 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06429749 |
92 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03926191 |
93 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01815127 |
94 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01365836 |
95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99720834 |
96 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99521884 |
97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97245957 |
98 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96781223 |
99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95539217 |
100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93940638 |
101 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92055159 |
102 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91328980 |
103 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.89162051 |
104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87182967 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86711101 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86711101 |
107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86048129 |
108 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86008858 |
109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85896752 |
110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83889517 |
111 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.83650125 |
112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83635011 |
113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82581578 |
114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81643565 |
115 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.81275114 |
116 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.80334753 |
117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77494971 |
118 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77236997 |
119 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76649632 |
120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75301182 |
121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74283289 |
122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73878914 |
123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73655256 |
124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73623458 |
125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73225640 |
126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72398814 |
127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70106512 |
128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69115489 |
129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.66248970 |
130 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65217890 |
131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64352005 |
132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60714209 |
133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60595183 |
134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60542197 |
135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60475828 |
136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60288624 |
137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60279903 |
138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60139126 |
139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59533839 |
140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.59075473 |
141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58128732 |
142 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55849322 |
143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55632759 |
144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55629234 |
145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55171613 |
146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52284217 |
147 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50818046 |
148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49845433 |
149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.49657746 |
150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49450706 |
151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47349272 |
152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47168133 |
153 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47143705 |
154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46681561 |
155 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46666037 |
156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46503003 |
157 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46011894 |
158 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.45528878 |
159 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44533761 |
160 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43705694 |
161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43193053 |
162 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.42230367 |
163 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.39570625 |
164 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.39448811 |
165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39354937 |
166 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39296764 |
167 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37532822 |
168 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37442087 |
169 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.37157557 |
170 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36941957 |
171 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36792924 |
172 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36170042 |
173 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.35900168 |
174 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.35413456 |
175 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.35413456 |
176 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.35218432 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.98307708 |
2 | MP0005360_urolithiasis | 7.09240356 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.15065914 |
4 | MP0005365_abnormal_bile_salt | 6.02497511 |
5 | MP0003941_abnormal_skin_development | 5.14004547 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05990481 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.95664538 |
8 | MP0003252_abnormal_bile_duct | 3.74646880 |
9 | MP0010329_abnormal_lipoprotein_level | 3.67260699 |
10 | MP0009840_abnormal_foam_cell | 3.10399676 |
11 | MP0005083_abnormal_biliary_tract | 2.93096960 |
12 | MP0005332_abnormal_amino_acid | 2.68105662 |
13 | MP0003195_calcinosis | 2.67791873 |
14 | MP0001666_abnormal_nutrient_absorption | 2.48308241 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.47280863 |
16 | MP0004957_abnormal_blastocyst_morpholog | 2.21733733 |
17 | MP0003693_abnormal_embryo_hatching | 2.19680861 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.18617963 |
19 | MP0000609_abnormal_liver_physiology | 2.18537075 |
20 | MP0004019_abnormal_vitamin_homeostasis | 2.13408876 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.93414509 |
22 | MP0004272_abnormal_basement_membrane | 1.88680571 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.83912879 |
24 | MP0003868_abnormal_feces_composition | 1.68279391 |
25 | MP0003011_delayed_dark_adaptation | 1.66086521 |
26 | MP0009379_abnormal_foot_pigmentation | 1.65993424 |
27 | MP0008007_abnormal_cellular_replicative | 1.65336067 |
28 | MP0008932_abnormal_embryonic_tissue | 1.59972791 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59796276 |
30 | MP0001764_abnormal_homeostasis | 1.59466136 |
31 | MP0003186_abnormal_redox_activity | 1.56511881 |
32 | MP0010094_abnormal_chromosome_stability | 1.52295817 |
33 | MP0009672_abnormal_birth_weight | 1.50167321 |
34 | MP0005670_abnormal_white_adipose | 1.43996063 |
35 | MP0009697_abnormal_copulation | 1.42284784 |
36 | MP0000579_abnormal_nail_morphology | 1.42166918 |
37 | MP0003111_abnormal_nucleus_morphology | 1.37164112 |
38 | MP0003890_abnormal_embryonic-extraembry | 1.37091910 |
39 | MP0008058_abnormal_DNA_repair | 1.33887156 |
40 | MP0010030_abnormal_orbit_morphology | 1.33502916 |
41 | MP0005451_abnormal_body_composition | 1.31458173 |
42 | MP0003705_abnormal_hypodermis_morpholog | 1.30165654 |
43 | MP0009643_abnormal_urine_homeostasis | 1.27894344 |
44 | MP0003950_abnormal_plasma_membrane | 1.27721124 |
45 | MP0003136_yellow_coat_color | 1.27187326 |
46 | MP0003566_abnormal_cell_adhesion | 1.23102826 |
47 | MP0003077_abnormal_cell_cycle | 1.21821964 |
48 | MP0006292_abnormal_olfactory_placode | 1.21718219 |
49 | MP0000762_abnormal_tongue_morphology | 1.21247314 |
50 | MP0002938_white_spotting | 1.19716512 |
51 | MP0004130_abnormal_muscle_cell | 1.18922075 |
52 | MP0002254_reproductive_system_inflammat | 1.18352650 |
53 | MP0005647_abnormal_sex_gland | 1.17775031 |
54 | MP0001293_anophthalmia | 1.16471833 |
55 | MP0000598_abnormal_liver_morphology | 1.15546714 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.15267418 |
57 | MP0009764_decreased_sensitivity_to | 1.14834126 |
58 | MP0002697_abnormal_eye_size | 1.07953308 |
59 | MP0010352_gastrointestinal_tract_polyps | 1.07123705 |
60 | MP0005501_abnormal_skin_physiology | 1.04700415 |
61 | MP0009763_increased_sensitivity_to | 1.04631617 |
62 | MP0000467_abnormal_esophagus_morphology | 1.02727453 |
63 | MP0000604_amyloidosis | 1.00227456 |
64 | MP0010368_abnormal_lymphatic_system | 0.98812478 |
65 | MP0002971_abnormal_brown_adipose | 0.95811095 |
66 | MP0002295_abnormal_pulmonary_circulatio | 0.95325183 |
67 | MP0008469_abnormal_protein_level | 0.92646663 |
68 | MP0001177_atelectasis | 0.91900155 |
69 | MP0005636_abnormal_mineral_homeostasis | 0.90460282 |
70 | MP0005666_abnormal_adipose_tissue | 0.87907754 |
71 | MP0005408_hypopigmentation | 0.87873153 |
72 | MP0005334_abnormal_fat_pad | 0.87829077 |
73 | MP0005275_abnormal_skin_tensile | 0.85912023 |
74 | MP0009642_abnormal_blood_homeostasis | 0.85876150 |
75 | MP0002876_abnormal_thyroid_physiology | 0.85023117 |
76 | MP0002090_abnormal_vision | 0.84263817 |
77 | MP0006036_abnormal_mitochondrial_physio | 0.83592307 |
78 | MP0000627_abnormal_mammary_gland | 0.83140279 |
79 | MP0003786_premature_aging | 0.83113195 |
80 | MP0005376_homeostasis/metabolism_phenot | 0.82075529 |
81 | MP0003724_increased_susceptibility_to | 0.81764355 |
82 | MP0002282_abnormal_trachea_morphology | 0.81333682 |
83 | MP0002078_abnormal_glucose_homeostasis | 0.80637180 |
84 | MP0003690_abnormal_glial_cell | 0.78464228 |
85 | MP0002111_abnormal_tail_morphology | 0.78361104 |
86 | MP0001730_embryonic_growth_arrest | 0.77398154 |
87 | MP0005535_abnormal_body_temperature | 0.77249950 |
88 | MP0009765_abnormal_xenobiotic_induced | 0.76929953 |
89 | MP0000350_abnormal_cell_proliferation | 0.76167202 |
90 | MP0005023_abnormal_wound_healing | 0.76065207 |
91 | MP0004782_abnormal_surfactant_physiolog | 0.74792932 |
92 | MP0001661_extended_life_span | 0.74416814 |
93 | MP0005084_abnormal_gallbladder_morpholo | 0.73976729 |
94 | MP0003937_abnormal_limbs/digits/tail_de | 0.69671051 |
95 | MP0009703_decreased_birth_body | 0.68133609 |
96 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67358227 |
97 | MP0000647_abnormal_sebaceous_gland | 0.66515586 |
98 | MP0005220_abnormal_exocrine_pancreas | 0.65629672 |
99 | MP0005266_abnormal_metabolism | 0.64838179 |
100 | MP0009053_abnormal_anal_canal | 0.64605149 |
101 | MP0001756_abnormal_urination | 0.64383775 |
102 | MP0002233_abnormal_nose_morphology | 0.63507152 |
103 | MP0002085_abnormal_embryonic_tissue | 0.62459870 |
104 | MP0005448_abnormal_energy_balance | 0.62324321 |
105 | MP0001286_abnormal_eye_development | 0.62055175 |
106 | MP0010771_integument_phenotype | 0.61868727 |
107 | MP0001697_abnormal_embryo_size | 0.61759223 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.61558484 |
109 | MP0000639_abnormal_adrenal_gland | 0.59563393 |
110 | MP0002796_impaired_skin_barrier | 0.59383628 |
111 | MP0009115_abnormal_fat_cell | 0.57500941 |
112 | MP0001881_abnormal_mammary_gland | 0.56865369 |
113 | MP0003436_decreased_susceptibility_to | 0.56415184 |
114 | MP0001672_abnormal_embryogenesis/_devel | 0.56399065 |
115 | MP0005380_embryogenesis_phenotype | 0.56399065 |
116 | MP0005503_abnormal_tendon_morphology | 0.56367571 |
117 | MP0002136_abnormal_kidney_physiology | 0.51229522 |
118 | MP0005464_abnormal_platelet_physiology | 0.51192269 |
119 | MP0003075_altered_response_to | 0.49633896 |
120 | MP0003329_amyloid_beta_deposits | 0.49528972 |
121 | MP0005395_other_phenotype | 0.47111520 |
122 | MP0006035_abnormal_mitochondrial_morpho | 0.46832432 |
123 | MP0002837_dystrophic_cardiac_calcinosis | 0.46469597 |
124 | MP0001853_heart_inflammation | 0.46153040 |
125 | MP0002970_abnormal_white_adipose | 0.46119862 |
126 | MP0009384_cardiac_valve_regurgitation | 0.45085488 |
127 | MP0005248_abnormal_Harderian_gland | 0.44743073 |
128 | MP0005164_abnormal_response_to | 0.44660316 |
129 | MP0003638_abnormal_response/metabolism_ | 0.44489377 |
130 | MP0002060_abnormal_skin_morphology | 0.44079515 |
131 | MP0005166_decreased_susceptibility_to | 0.43320421 |
132 | MP0004883_abnormal_blood_vessel | 0.43040145 |
133 | MP0004381_abnormal_hair_follicle | 0.42938172 |
134 | MP0008873_increased_physiological_sensi | 0.42510439 |
135 | MP0003953_abnormal_hormone_level | 0.42431816 |
136 | MP0002928_abnormal_bile_duct | 0.41517579 |
137 | MP0005058_abnormal_lysosome_morphology | 0.41357703 |
138 | MP0000249_abnormal_blood_vessel | 0.40354929 |
139 | MP0002168_other_aberrant_phenotype | 0.39446279 |
140 | MP0002132_abnormal_respiratory_system | 0.37864060 |
141 | MP0005375_adipose_tissue_phenotype | 0.37770174 |
142 | MP0010234_abnormal_vibrissa_follicle | 0.37605139 |
143 | MP0000230_abnormal_systemic_arterial | 0.37541750 |
144 | MP0008874_decreased_physiological_sensi | 0.36716301 |
145 | MP0001845_abnormal_inflammatory_respons | 0.33736818 |
146 | MP0006082_CNS_inflammation | 0.33672792 |
147 | MP0008438_abnormal_cutaneous_collagen | 0.33164630 |
148 | MP0003718_maternal_effect | 0.32509011 |
149 | MP0003453_abnormal_keratinocyte_physiol | 0.31857403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.05682280 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.96394530 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.95410156 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.29740151 |
5 | Xanthomatosis (HP:0000991) | 6.24884774 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.17784767 |
7 | Hypobetalipoproteinemia (HP:0003563) | 6.08559874 |
8 | Complement deficiency (HP:0004431) | 5.55752826 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.54679057 |
10 | Hypolipoproteinemia (HP:0010981) | 4.73336415 |
11 | Epidermoid cyst (HP:0200040) | 4.68152490 |
12 | Hyperammonemia (HP:0001987) | 4.60921726 |
13 | Joint hemorrhage (HP:0005261) | 4.56129321 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43205400 |
15 | Hyperglycinemia (HP:0002154) | 4.42973120 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.28509419 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.26268470 |
18 | Ketosis (HP:0001946) | 4.25089452 |
19 | Hyperglycinuria (HP:0003108) | 4.17197109 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09086955 |
21 | Abnormality of glycine metabolism (HP:0010895) | 4.08671877 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08671877 |
23 | Abnormality of complement system (HP:0005339) | 4.08048299 |
24 | Hypoglycemic coma (HP:0001325) | 4.07632993 |
25 | Fat malabsorption (HP:0002630) | 4.00667558 |
26 | Abnormality of methionine metabolism (HP:0010901) | 3.96156772 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95475608 |
28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.92643765 |
29 | Hypercholesterolemia (HP:0003124) | 3.71079745 |
30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.62328023 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60071320 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55029459 |
33 | Reduced antithrombin III activity (HP:0001976) | 3.51955622 |
34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.49909484 |
35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48448874 |
36 | Acute encephalopathy (HP:0006846) | 3.42789103 |
37 | Increased serum pyruvate (HP:0003542) | 3.36016294 |
38 | Hyperbilirubinemia (HP:0002904) | 3.17060086 |
39 | Acute necrotizing encephalopathy (HP:0006965) | 3.14241373 |
40 | Abnormality of glycolysis (HP:0004366) | 3.12140057 |
41 | Myocardial infarction (HP:0001658) | 3.11821200 |
42 | Ketoacidosis (HP:0001993) | 3.10008562 |
43 | Steatorrhea (HP:0002570) | 3.07164466 |
44 | Abnormality of serum amino acid levels (HP:0003112) | 3.06933190 |
45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03459489 |
46 | Delayed CNS myelination (HP:0002188) | 2.96468726 |
47 | Hepatocellular carcinoma (HP:0001402) | 2.95151484 |
48 | Systemic lupus erythematosus (HP:0002725) | 2.90350357 |
49 | Skin nodule (HP:0200036) | 2.90184416 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.80234492 |
51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.78274473 |
52 | Dicarboxylic aciduria (HP:0003215) | 2.78273539 |
53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78273539 |
54 | Metabolic acidosis (HP:0001942) | 2.77877883 |
55 | Renal Fanconi syndrome (HP:0001994) | 2.77373048 |
56 | Spontaneous abortion (HP:0005268) | 2.76621123 |
57 | Increased hepatocellular lipid droplets (HP:0006565) | 2.75027540 |
58 | Septo-optic dysplasia (HP:0100842) | 2.66530485 |
59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.65808523 |
60 | Lethargy (HP:0001254) | 2.65126124 |
61 | Megaloblastic anemia (HP:0001889) | 2.64050640 |
62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62348364 |
63 | Hypochromic microcytic anemia (HP:0004840) | 2.61724144 |
64 | Multiple enchondromatosis (HP:0005701) | 2.57796393 |
65 | Macrocytic anemia (HP:0001972) | 2.52821025 |
66 | Vascular calcification (HP:0004934) | 2.51909594 |
67 | Type I transferrin isoform profile (HP:0003642) | 2.51029778 |
68 | Mitochondrial inheritance (HP:0001427) | 2.48735983 |
69 | Cerebral edema (HP:0002181) | 2.48140871 |
70 | Glomerulonephritis (HP:0000099) | 2.42012283 |
71 | Spastic diplegia (HP:0001264) | 2.41948793 |
72 | Progressive macrocephaly (HP:0004481) | 2.40723731 |
73 | Hypoglycemic seizures (HP:0002173) | 2.37980485 |
74 | Gout (HP:0001997) | 2.37877177 |
75 | Congenital, generalized hypertrichosis (HP:0004540) | 2.36970199 |
76 | Sparse eyelashes (HP:0000653) | 2.35653663 |
77 | Increased CSF lactate (HP:0002490) | 2.35232549 |
78 | Acanthocytosis (HP:0001927) | 2.35202468 |
79 | Amyloidosis (HP:0011034) | 2.34739396 |
80 | Abnormal gallbladder morphology (HP:0012437) | 2.34488297 |
81 | Hepatic necrosis (HP:0002605) | 2.33812730 |
82 | Generalized aminoaciduria (HP:0002909) | 2.29545644 |
83 | Cholelithiasis (HP:0001081) | 2.28476480 |
84 | Esophageal varix (HP:0002040) | 2.28078507 |
85 | Pancreatitis (HP:0001733) | 2.27586528 |
86 | Mitral stenosis (HP:0001718) | 2.26561865 |
87 | Cardiovascular calcification (HP:0011915) | 2.26100125 |
88 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.23375015 |
89 | Brushfield spots (HP:0001088) | 2.23019254 |
90 | Neonatal onset (HP:0003623) | 2.22653703 |
91 | Irritability (HP:0000737) | 2.22191393 |
92 | Hepatocellular necrosis (HP:0001404) | 2.19283650 |
93 | Cholecystitis (HP:0001082) | 2.18570199 |
94 | Abnormal gallbladder physiology (HP:0012438) | 2.18570199 |
95 | Abnormality of vitamin metabolism (HP:0100508) | 2.17421533 |
96 | Abnormal cartilage morphology (HP:0002763) | 2.15687038 |
97 | Vomiting (HP:0002013) | 2.14963940 |
98 | Sensorimotor neuropathy (HP:0007141) | 2.14505816 |
99 | Malnutrition (HP:0004395) | 2.14280838 |
100 | Hyperphosphaturia (HP:0003109) | 2.13780428 |
101 | Methylmalonic acidemia (HP:0002912) | 2.12986713 |
102 | Reticulocytopenia (HP:0001896) | 2.11849619 |
103 | Colon cancer (HP:0003003) | 2.11723155 |
104 | Abnormality of urine glucose concentration (HP:0011016) | 2.10125321 |
105 | Glycosuria (HP:0003076) | 2.10125321 |
106 | Abnormality of proline metabolism (HP:0010907) | 2.10073886 |
107 | Hydroxyprolinuria (HP:0003080) | 2.10073886 |
108 | Hemorrhage of the eye (HP:0011885) | 2.09614867 |
109 | Gingival bleeding (HP:0000225) | 2.09181185 |
110 | Renal cortical cysts (HP:0000803) | 2.08303635 |
111 | Hypertriglyceridemia (HP:0002155) | 2.04847599 |
112 | Late onset (HP:0003584) | 2.00643877 |
113 | Enlarged kidneys (HP:0000105) | 2.00538886 |
114 | Nausea (HP:0002018) | 1.99963584 |
115 | Menorrhagia (HP:0000132) | 1.99549016 |
116 | Abnormality of the labia minora (HP:0012880) | 1.99423977 |
117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98233410 |
118 | Abnormality of alanine metabolism (HP:0010916) | 1.98233410 |
119 | Hyperalaninemia (HP:0003348) | 1.98233410 |
120 | Thrombophlebitis (HP:0004418) | 1.97426852 |
121 | Opisthotonus (HP:0002179) | 1.96169946 |
122 | Oral leukoplakia (HP:0002745) | 1.95389593 |
123 | Abnormality of the gallbladder (HP:0005264) | 1.90627605 |
124 | Nephritis (HP:0000123) | 1.89429960 |
125 | Abnormality of iron homeostasis (HP:0011031) | 1.89071307 |
126 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87580680 |
127 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87580680 |
128 | Abnormal protein glycosylation (HP:0012346) | 1.87580680 |
129 | Abnormal glycosylation (HP:0012345) | 1.87580680 |
130 | Methylmalonic aciduria (HP:0012120) | 1.86540145 |
131 | Symptomatic seizures (HP:0011145) | 1.86528175 |
132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85438876 |
133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85339906 |
134 | Elevated hepatic transaminases (HP:0002910) | 1.84526242 |
135 | Proximal tubulopathy (HP:0000114) | 1.83694875 |
136 | Rickets (HP:0002748) | 1.83454927 |
137 | Increased muscle lipid content (HP:0009058) | 1.80041797 |
138 | Increased purine levels (HP:0004368) | 1.78825014 |
139 | Hyperuricemia (HP:0002149) | 1.78825014 |
140 | Hyperglycemia (HP:0003074) | 1.78410699 |
141 | Selective tooth agenesis (HP:0001592) | 1.78319008 |
142 | Abnormality of renal resorption (HP:0011038) | 1.77698884 |
143 | Poikilocytosis (HP:0004447) | 1.76423851 |
144 | Exertional dyspnea (HP:0002875) | 1.75547417 |
145 | Birth length less than 3rd percentile (HP:0003561) | 1.74538831 |
146 | Lactic acidosis (HP:0003128) | 1.73911726 |
147 | Stenosis of the external auditory canal (HP:0000402) | 1.73260596 |
148 | Increased serum lactate (HP:0002151) | 1.72071835 |
149 | Abnormal lung lobation (HP:0002101) | 1.71558554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.74959466 |
2 | SIK1 | 4.52962825 |
3 | ERN1 | 4.40290589 |
4 | FGFR4 | 4.02123080 |
5 | VRK2 | 3.89759337 |
6 | MST4 | 3.76214126 |
7 | BUB1 | 3.64019460 |
8 | TTK | 2.95333889 |
9 | CDC7 | 2.94595179 |
10 | INSRR | 2.65124560 |
11 | ERBB4 | 2.46234492 |
12 | MST1R | 2.45337584 |
13 | TAOK3 | 2.43294765 |
14 | BRSK2 | 2.31644602 |
15 | STK16 | 2.30764647 |
16 | TRIB3 | 2.27782833 |
17 | NEK1 | 2.24903128 |
18 | TSSK6 | 2.21287726 |
19 | EIF2AK3 | 2.14736659 |
20 | SRPK1 | 2.09815744 |
21 | TAF1 | 2.09131771 |
22 | PLK3 | 2.02887243 |
23 | PKN2 | 2.02878638 |
24 | NME1 | 1.95922429 |
25 | EIF2AK1 | 1.88402513 |
26 | MKNK1 | 1.86150924 |
27 | PAK4 | 1.86050525 |
28 | MKNK2 | 1.85286916 |
29 | MAP3K12 | 1.82707479 |
30 | FRK | 1.81414897 |
31 | TNIK | 1.74447692 |
32 | MAP2K4 | 1.72596726 |
33 | LATS1 | 1.71406545 |
34 | NEK9 | 1.69348644 |
35 | MAPK11 | 1.66535091 |
36 | PIK3CG | 1.65985490 |
37 | NME2 | 1.64593731 |
38 | TYK2 | 1.63825073 |
39 | FLT3 | 1.61511453 |
40 | VRK1 | 1.60076625 |
41 | LATS2 | 1.58807917 |
42 | DAPK2 | 1.57890849 |
43 | CAMK1D | 1.52664637 |
44 | EPHA2 | 1.52354910 |
45 | ZAK | 1.49565352 |
46 | PTK6 | 1.46920947 |
47 | ABL2 | 1.46138166 |
48 | WEE1 | 1.39883479 |
49 | FGFR2 | 1.37696873 |
50 | TRIM28 | 1.36614467 |
51 | PLK1 | 1.34449952 |
52 | NUAK1 | 1.31027378 |
53 | ACVR1B | 1.25935647 |
54 | MAP3K3 | 1.25694372 |
55 | BMPR1B | 1.24160318 |
56 | PRKAA2 | 1.20796313 |
57 | JAK2 | 1.20575727 |
58 | TBK1 | 1.19557978 |
59 | KDR | 1.18995671 |
60 | MAP2K3 | 1.15861813 |
61 | MAP3K14 | 1.14798094 |
62 | PLK4 | 1.12639804 |
63 | IRAK3 | 1.12344081 |
64 | JAK1 | 1.10890082 |
65 | TGFBR2 | 1.09881608 |
66 | EPHB1 | 1.03794409 |
67 | CDK6 | 1.02578096 |
68 | RIPK1 | 1.02524625 |
69 | MAP3K7 | 1.00916573 |
70 | STK24 | 0.99096724 |
71 | WNK3 | 0.94594031 |
72 | TIE1 | 0.92544753 |
73 | EPHA3 | 0.92436817 |
74 | ERBB2 | 0.92204757 |
75 | AURKB | 0.91857272 |
76 | BRSK1 | 0.91469991 |
77 | MET | 0.90133859 |
78 | EIF2AK2 | 0.89116510 |
79 | PINK1 | 0.88620460 |
80 | MAP3K10 | 0.87495752 |
81 | MAPK4 | 0.86488732 |
82 | STK38L | 0.83968257 |
83 | FGFR3 | 0.79082446 |
84 | PRKCZ | 0.78028534 |
85 | FGFR1 | 0.77098401 |
86 | TESK1 | 0.76323111 |
87 | MAP3K11 | 0.74538984 |
88 | PBK | 0.74500007 |
89 | MAPK15 | 0.74208463 |
90 | CSK | 0.73941317 |
91 | DYRK3 | 0.73664329 |
92 | GRK6 | 0.72651670 |
93 | GSK3A | 0.71655425 |
94 | NLK | 0.70763472 |
95 | CAMK1G | 0.70614125 |
96 | IKBKE | 0.70016364 |
97 | PDK4 | 0.69747065 |
98 | PDK3 | 0.69747065 |
99 | PRKACG | 0.68633628 |
100 | MAP2K1 | 0.68533894 |
101 | MAPK12 | 0.66377957 |
102 | EPHB2 | 0.64884489 |
103 | ARAF | 0.64577467 |
104 | CHEK2 | 0.63111349 |
105 | RPS6KB2 | 0.62465588 |
106 | MAPKAPK3 | 0.62411740 |
107 | ALK | 0.62125104 |
108 | CSNK2A1 | 0.59934584 |
109 | DYRK2 | 0.59084612 |
110 | CDK7 | 0.57702279 |
111 | PRKAA1 | 0.57294768 |
112 | MAP2K6 | 0.57157238 |
113 | CAMK2G | 0.56514105 |
114 | PTK2 | 0.56301391 |
115 | IGF1R | 0.56272686 |
116 | BCR | 0.55018638 |
117 | DYRK1B | 0.55002711 |
118 | CSNK1E | 0.54740687 |
119 | PDPK1 | 0.54680424 |
120 | GRK1 | 0.54420808 |
121 | TGFBR1 | 0.54229732 |
122 | SGK3 | 0.54189282 |
123 | CSNK2A2 | 0.53831732 |
124 | OXSR1 | 0.53039516 |
125 | PAK2 | 0.52046645 |
126 | ILK | 0.51412865 |
127 | PIK3CA | 0.50351112 |
128 | CSF1R | 0.49515704 |
129 | MAP3K13 | 0.49350837 |
130 | PRKCI | 0.47726826 |
131 | IRAK1 | 0.44077275 |
132 | MAPK7 | 0.43549326 |
133 | STK39 | 0.43020686 |
134 | PDK2 | 0.42714062 |
135 | FER | 0.41776253 |
136 | TAOK2 | 0.41078613 |
137 | PRKCQ | 0.40579931 |
138 | ATR | 0.40260300 |
139 | NEK2 | 0.40152701 |
140 | PRKCE | 0.39975979 |
141 | MYLK | 0.39657107 |
142 | DAPK1 | 0.39269090 |
143 | STK4 | 0.39082696 |
144 | MAP3K2 | 0.38145938 |
145 | CHEK1 | 0.37432694 |
146 | SGK2 | 0.37319938 |
147 | LIMK1 | 0.36466574 |
148 | MUSK | 0.36091531 |
149 | MAP3K5 | 0.35913650 |
150 | SCYL2 | 0.35806063 |
151 | MAPKAPK5 | 0.35694458 |
152 | CDK9 | 0.35035247 |
153 | BMX | 0.34721338 |
154 | CDK4 | 0.34465208 |
155 | CSNK1G1 | 0.34225578 |
156 | RET | 0.33432929 |
157 | ABL1 | 0.33251135 |
158 | STK3 | 0.33165695 |
159 | EGFR | 0.31789293 |
160 | ATM | 0.31569015 |
161 | TEC | 0.30447380 |
162 | AURKA | 0.29706384 |
163 | PDK1 | 0.29701499 |
164 | IRAK2 | 0.29311767 |
165 | MAP3K8 | 0.28995178 |
166 | MAP3K1 | 0.28575573 |
167 | DDR2 | 0.27997661 |
168 | MTOR | 0.27951536 |
169 | CHUK | 0.27726089 |
170 | PNCK | 0.27309348 |
171 | ZAP70 | 0.27046059 |
172 | MAP2K2 | 0.26939183 |
173 | ITK | 0.24602944 |
174 | PDGFRA | 0.24597875 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34620552 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38541258 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34862502 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01119940 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.85634785 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77094013 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65934201 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63455325 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62720829 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57151135 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52322918 |
12 | Proteasome_Homo sapiens_hsa03050 | 2.51295916 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37826959 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34880831 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.17582079 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17337585 |
17 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15122027 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12070235 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11208873 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01993482 |
21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97636493 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94975368 |
23 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94604569 |
24 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94147954 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89008177 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80000278 |
27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.79607503 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78990325 |
29 | Ribosome_Homo sapiens_hsa03010 | 1.76737483 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72359173 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64830142 |
32 | Mismatch repair_Homo sapiens_hsa03430 | 1.62444900 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57276799 |
34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56309354 |
35 | Protein export_Homo sapiens_hsa03060 | 1.55972061 |
36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55938895 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53049694 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52879151 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50159202 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46665424 |
41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46364011 |
42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44679680 |
43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44228828 |
44 | DNA replication_Homo sapiens_hsa03030 | 1.42768209 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41780869 |
46 | Bile secretion_Homo sapiens_hsa04976 | 1.38216848 |
47 | RNA polymerase_Homo sapiens_hsa03020 | 1.36594722 |
48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36037354 |
49 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33384095 |
50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33116398 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20825157 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20424394 |
53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19148163 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19032210 |
55 | ABC transporters_Homo sapiens_hsa02010 | 1.15671401 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13638561 |
57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11728411 |
58 | Homologous recombination_Homo sapiens_hsa03440 | 1.08808240 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03456747 |
60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99127508 |
61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97787935 |
62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97722276 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91120743 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90251398 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88063714 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87016282 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84765212 |
68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83740787 |
69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81613150 |
70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81067239 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80374526 |
72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80074752 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78489419 |
74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.76860583 |
75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74549280 |
76 | Lysine degradation_Homo sapiens_hsa00310 | 0.74090060 |
77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73369128 |
78 | Base excision repair_Homo sapiens_hsa03410 | 0.73031127 |
79 | Spliceosome_Homo sapiens_hsa03040 | 0.73005294 |
80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72991934 |
81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69399261 |
82 | RNA transport_Homo sapiens_hsa03013 | 0.69211942 |
83 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.66629724 |
84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62391372 |
85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55814580 |
86 | RNA degradation_Homo sapiens_hsa03018 | 0.46927840 |
87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45997377 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44971482 |
89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44573946 |
90 | Purine metabolism_Homo sapiens_hsa00230 | 0.43837891 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.41040907 |
92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37067283 |
93 | Prion diseases_Homo sapiens_hsa05020 | 0.35416162 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34169830 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32971117 |
96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30668853 |
97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28336743 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.27564602 |
99 | Mineral absorption_Homo sapiens_hsa04978 | 0.23872579 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23493003 |
101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21577738 |
102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16931537 |
103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16829959 |
104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15917694 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14307667 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08582791 |
107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08521269 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06807086 |
109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2160751 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.2145061 |
111 | Bladder cancer_Homo sapiens_hsa05219 | -0.2058407 |
112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2048718 |
113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2037870 |
114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2001922 |
115 | Lysosome_Homo sapiens_hsa04142 | -0.1899089 |
116 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1860206 |
117 | Pertussis_Homo sapiens_hsa05133 | -0.1737463 |
118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1709552 |
119 | Amoebiasis_Homo sapiens_hsa05146 | -0.1665995 |
120 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1562324 |
121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1266972 |
122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1258618 |
123 | Hepatitis C_Homo sapiens_hsa05160 | -0.1195327 |
124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1031544 |
125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0852283 |
126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0700020 |
127 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0682748 |
128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0202946 |